{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:30:23Z","timestamp":1790487023410,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":1421,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS100529"],"award-info":[{"award-number":["NS100529"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13311-019-00823-3","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T10:03:25Z","timestamp":1578305005000},"page":"924-927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Repeat Expansion Disorders: Mechanisms and Therapeutics"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-7977","authenticated-orcid":false,"given":"Lisa M.","family":"Ellerby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1007\/s13311-019-00823-3_bib1","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1074\/jbc.274.13.8730","article-title":"Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity","volume":"274","author":"Ellerby","year":"1999","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1007\/s13311-019-00823-3_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1471-4159.1999.0720185.x","article-title":"Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity","volume":"72","author":"Ellerby","year":"1999","journal-title":"J Neurochem."},{"issue":"19","key":"10.1007\/s13311-019-00823-3_bib3","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J Biol Chem."},{"issue":"22","key":"10.1007\/s13311-019-00823-3_bib4","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1523\/JNEUROSCI.6379-11.2012","article-title":"Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment","volume":"32","author":"Gafni","year":"2012","journal-title":"J Neurosci."},{"issue":"37","key":"10.1007\/s13311-019-00823-3_bib5","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M302841200","article-title":"Kennedy's disease. Phosphorylation of the polyglutamine-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death","volume":"278","author":"LaFevre-Bernt","year":"2003","journal-title":"J Biol Chem."},{"issue":"11","key":"10.1007\/s13311-019-00823-3_bib6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.chembiol.2010.08.014","article-title":"Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models","volume":"17","author":"Leyva","year":"2010","journal-title":"Chem Biol."},{"issue":"18","key":"10.1007\/s13311-019-00823-3_bib7","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J Neurosci."},{"issue":"15","key":"10.1007\/s13311-019-00823-3_bib8","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","article-title":"Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract","volume":"273","author":"Wellington","year":"1998","journal-title":"J Biol Chem."},{"issue":"26","key":"10.1007\/s13311-019-00823-3_bib9","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M001475200","article-title":"Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells","volume":"275","author":"Wellington","year":"2000","journal-title":"J Biol Chem."},{"issue":"6330","key":"10.1007\/s13311-019-00823-3_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature."},{"key":"10.1007\/s13311-019-00823-3_bib11","series-title":"Merry DE","author":"Arnold","year":"2019"},{"issue":"6","key":"10.1007\/s13311-019-00823-3_bib12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.","volume":"72","year":"1993","journal-title":"Cell."},{"key":"10.1007\/s13311-019-00823-3_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00768-7","article-title":"DNA Damage Repair in Huntington's Disease and Other Neurodegenerative Diseases.","author":"Maiuri","year":"2019","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-019-00823-3_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00782-9","article-title":"Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models","author":"Creus-Muncunill","year":"2019","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-019-00823-3_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00810-8","article-title":"Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells","author":"Naphade","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"3","key":"10.1007\/s13311-019-00823-3_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1","volume":"4","author":"Orr","year":"1993","journal-title":"Nat Genet."},{"key":"10.1007\/s13311-019-00823-3_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00763-y","article-title":"Moving Towards Therapy in SCA1: Insights from Molecular Mechanisms, Identification of Novel Targets, and Planning for Human Trials","author":"Srinivasan","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"3","key":"10.1007\/s13311-019-00823-3_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng0793-300","article-title":"The gene for Machado-Joseph disease maps to human chromosome 14q","volume":"4","author":"Takiyama","year":"1993","journal-title":"Nat Genet."},{"key":"10.1007\/s13311-019-00823-3_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00798-1","article-title":"From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.","author":"Da Silva","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"5254","key":"10.1007\/s13311-019-00823-3_bib20","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science."},{"key":"10.1007\/s13311-019-00823-3_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00764-x","article-title":"Molecular Mechanisms and Therapeutics for the GAA.TTC Expansion Disease Friedreich Ataxia","author":"Gottesfeld","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"3","key":"10.1007\/s13311-019-00823-3_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng1196-285","article-title":"Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats","volume":"14","author":"Imbert","year":"1996","journal-title":"Nat Genet."},{"issue":"3","key":"10.1007\/s13311-019-00823-3_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1196-269","article-title":"Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2","volume":"14","author":"Pulst","year":"1996","journal-title":"Nat Genet."},{"issue":"3","key":"10.1007\/s13311-019-00823-3_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng1196-277","article-title":"Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique","volume":"14","author":"Sanpei","year":"1996","journal-title":"DIRECT. Nat Genet."},{"key":"10.1007\/s13311-019-00823-3_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00777-6","article-title":"Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2","author":"Egorova","year":"2019","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-019-00823-3_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00778-5","article-title":"Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7","author":"Niewiadomska-Cimicka","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"11","key":"10.1007\/s13311-019-00823-3_bib27","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/hmg\/8.11.2047","article-title":"A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?","volume":"8","author":"Koide","year":"1999","journal-title":"Hum Mol Genet."},{"key":"10.1007\/s13311-019-00823-3_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00762-z","article-title":"Molecular Mechanisms and Therapeutics for SCA17","author":"Liu","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"5","key":"10.1007\/s13311-019-00823-3_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajhg.2009.09.019","article-title":"Spinocerebellar ataxia type 31 is associated with \u201cinserted\u201d penta-nucleotide repeats containing (TGGAA)n","volume":"85","author":"Sato","year":"2009","journal-title":"Am J Hum Genet."},{"key":"10.1007\/s13311-019-00823-3_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00804-6","article-title":"Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31)","author":"Ishikawa","year":"2019","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-019-00823-3_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00797-2","article-title":"Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis\/Frontotemporal Dementia","author":"Jiang","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"4","key":"10.1007\/s13311-019-00823-3_bib32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/WCO.0000000000000708","article-title":"X-Linked Dystonia-Parkinsonism: recent advances","volume":"32","author":"Bragg","year":"2019","journal-title":"Curr Opin Neurol."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00823-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00823-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00823-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:44:51Z","timestamp":1761806691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1878747923009595"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00823-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeat Expansion Disorders: Mechanisms and Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00823-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}